Abstrakti
AI enhances healthcare by optimizing medication timing through circadian rhythm analysis. It uses data from prescriptions, health records, DNA, and wearable sensors to predict compliance, minimize adverse effects, and improve treatment for diseases like cancer and heart conditions. By analyzing genetic and epigenetic data, AI tailors drug schedules to individual chronotypes, synchronizing therapies with biological rhythms for better outcomes. Collaboration among clinicians, researchers, and ethicists drives advancements in personalized medicine, leveraging automated systems and precision dosing to improve adherence and efficacy. Despite challenges like data privacy, AI promises revolutionary progress in drug scheduling, enabling more accurate, personalized, and effective treatments for improved patient care.
| Alkuperäiskieli | Englanti |
|---|---|
| Otsikko | Chronopharmacology |
| Alaotsikko | Time-Dependent Pharmacotherapy |
| Kustantaja | CRC press |
| Sivut | 164-179 |
| Sivumäärä | 16 |
| ISBN (elektroninen) | 9781040594841 |
| ISBN (painettu) | 9781041067191 |
| DOI - pysyväislinkit | |
| Tila | Julkaistu - 18 marrask. 2025 |
| OKM-julkaisutyyppi | A3 Kirjan osa tai toinen tutkimuskirja |
Sormenjälki
Sukella tutkimusaiheisiin 'The Role of Artificial Intelligence in Optimizing Drug Timing'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.Viittausmuodot
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver